CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...